Pranidipine

From WikiProjectMed
Jump to navigation Jump to search
Pranidipine
Names
Preferred IUPAC name
Methyl (2E)-3-phenylprop-2-en-1-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
Other names
2,6-Dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid O5-methyl O3-[(E)-3-phenylprop-2-enyl] ester
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
MeSH C048161
UNII
  • InChI=1S/C25H24N2O6/c1-16-21(24(28)32-3)23(19-12-7-13-20(15-19)27(30)31)22(17(2)26-16)25(29)33-14-8-11-18-9-5-4-6-10-18/h4-13,15,23,26H,14H2,1-3H3/b11-8+ ☒N
    Key: XTFPDGZNWTZCMF-DHZHZOJOSA-N ☒N
  • InChI=1/C25H24N2O6/c1-16-21(24(28)32-3)23(19-12-7-13-20(15-19)27(30)31)22(17(2)26-16)25(29)33-14-8-11-18-9-5-4-6-10-18/h4-13,15,23,26H,14H2,1-3H3/b11-8+
    Key: XTFPDGZNWTZCMF-DHZHZOJOBA
  • CC1=C(C(C(=C(N1)C)C(=O)OCC=CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC
Properties
C25H24N2O6
Molar mass 448.46786
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)

Pranidipine is a calcium channel blocker. It is a long acting calcium channel antagonist of the dihydropyridine group.[1]

References

  1. ^ Jin Yang; Keisuke Fukuo; Shigeto Morimoto; Tadaaki Niinobu; Toshimitsu Suhara; Toshio Ogihara (2000). "Pranidipine Enhances the Action of Nitric Oxide Released From Endothelial Cells". Hypertension. 35 (1 Pt 1): 82–85. doi:10.1161/01.hyp.35.1.82. PMID 10642279.